Aptahem teams up with Hongene

Aptahem, a biotech company developing RNA-based treatments for severe inflammatory conditions, announces a strategic collaboration with Hongene Biotech, a global leader in RNA and Oligo manufacturing.

The partnership aims to explore and implement new, cutting-edge production methods that significantly reduce manufacturing costs and enhance sustainability for Aptahem’s lead candidate, Apta-1.